Sunac Services suddenly surged 9%, making me doubt my own eyes. Having been taught a lesson by property stocks before, I don't dare chase the rebound now. On the pharmaceutical side, Hengrui and Geli seem ready to take off, and there are also obscure tickets like Maoji Kuiyong, but I'm too afraid to touch them, fearing I'll miss out. Only the slight gains of New China Life Insurance look more like a token gesture, but big money is probably still hesitating on the sidelines.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
